Nicotine dependent individuals among the tobacco users are in greater risk of having tobacco related disease and psychiatric co-morbidities. There is little information about the tobacco use and nicotine dependence among psychiatric patients in developing countries including Nepal. This study was done to estimate the prevalence of tobacco use, the level of nicotine dependence among the users and the psychiatric disorder specific prevalence among tobacco users admitted in psychiatry ward.
INTRODUCTION
Nicotine present in tobacco products is the key chemical compound which is highly addictive. Assessing nicotine dependence is of utmost importance in tobacco users. Dependent smokers are reported to have greater functional impairment than nondependent smokers, it is possible that nicotine dependence confers greater risk of shortterm and long-term adverse health outcomes than smoking alone. 1 There seems always a need of assessment of psychiatric disorders in nicotine dependent individuals as psychiatric co-morbidity is one of the factors associated with a poorer outcome in treatment of such individuals. It is seen that nicotine dependence and smoking are two to three times more common in individuals with psychiatric and other substance use disorders than in the general population. 2 Conversely, the high rates of psychiatric disorders amongst smokers are common throughout the world. 3 Heavy smokers have more severe psychiatric symptoms and poorer overall general well-being. 4 Little is known about the prevalence of tobacco use, nicotine dependence among tobacco users and co-occurrence of nicotine dependence and psychiatric disorder in developing countries including Nepal. Therefore, this study was carried out to estimate the prevalence of tobacco users in admitted patients in psychiatric facility and the level of nicotine dependence among users. We also aim to estimate the psychiatric disorder specific prevalence among tobacco users. 
MATERIAL AND METHOD

Sample size and study population
Keeping the estimated prevalence 55% of tobacco users in hospital setting with β error at 0.2, sample size came out to be 82. Additional 10% subjects were taken for better representation which makes 90. All consecutive patients admitted in ward who gave informed consent were enrolled. Those who were unwilling or unable to give informed consent and participate in the research were excluded. Acutely ill patients were enrolled only after they improved from the acute phase of illness. 
Instruments
DISCUSSION:
Our study showed the prevalence of tobacco use to be significantly high (62.2%) in admitted patients. Fifty six patients consumed one or other forms of tobacco. More participants were from the age group of (36-45) years, but the tobacco use was more prevalent in those who were 46 years and above (76.9%). Gender wise, out of 57 male patients, 46 (80.7%) males consumed tobacco and 10 (30.3%) females consumed tobacco. Majority of females (69.7%) did not consume tobacco. This was found to be statistically significant (p< 0.05). A study done in an In-patient setting in Iran showed the prevalence of smoking was 70%. Seventy eight percent of males consumed tobacco which was higher compared to females (36.2%). 5 Our finding is similar in this regard. Another study in NIHMANS, in an in-patient psychiatric facility showed that prevalence of overall tobacco use was 36%. Majority of tobacco users (88%) were 39 years and above. Prevalence of tobacco use was found to be 53% in male patients compared to 9% in females. 6 McClave et al 7 had also found that prevalence of smoking was significantly higher in persons having mental illness similar to those admitted in our wards which can range from 40% to 85%. Our study showed 78.57% of tobacco users were consuming smokeless form of tobacco, 14.29% were smoking and 7.14% were taking both forms of tobacco. Chandra et al 6 study showed the prevalence of smokeless form such as chewing form was among 9% of patients and smoking was observed in 7% ( including cigarettes and beedis); whereas 4% consumed both forms of tobacco. Smokeless tobacco, being easy in access and use in day to day life, may be more widely used than smoking in our setting. Smoking form, on the other hand, may be easily noticeable and many consider it as more dangerous form than smokeless form. Majority of tobacco users in present study had moderate nicotine dependence (60.71%), followed by high/ severe nicotine dependence (35.71%). Only few (3.5%) had a low dependence on nicotine. It implies the fact that psychiatric patients, who are in their active illness phase, are moderately to highly dependent on nicotine. This finding is consistent with a study by Chandra PS et al where 65% of all tobacco users admitted for their psychiatric illness reported of moderate to severe nicotine dependence. 6 Another study in western country reported that the associations between nicotine dependence and specific Axis I and II disorders were all strong and statistically significant. 8 Out of 56 tobacco users, highest prevalence of psychotic disorder (33.3%) was observed. It includes schizophrenia, acute and transient psychotic disorder and unspecified nonorganic psychosis, organic psychosis etc. Second most common diagnosis was manic and hypomanic episodes (32.1%). Nearly one-third (17/20) of tobacco users received diagnosis of alcohol dependence. In-patient alcohol dependence study of the same department reported 70% prevalence of nicotine use/abuse. 9 Chandra PS et al 6 study showed that among in-patient tobacco users, most common primary diagnosis was mood disorder (47%) including both bipolar illness and major depressive disorder which was followed by psychotic disorder (39%) and Neurotic disorder (14%). As known, tobacco use is high among psychiatric patients compared to those without illness and conversely, some of the study has also shown that tobacco consumption may itself be risk There are certain limitations in present study. Though our study focused primarily on tobacco use and dependence and based upon our instruments, our effort was exclusively to obtain the related information, however, because of denial or minimization, underreporting in substance taking behavior may be possible. Chances of bias may occur as the questionnaire and tools utilized were entirely based upon subjective reporting. Because of the cross-sectional nature of the study, temporal relation between the independent variables and tobacco use could not be established. Moreover, chronicity of psychiatric illness and effects of medication on tobacco use patterns were not assessed.
CONCLUSION:
The prevalence of tobacco use was significantly high. This shows there is high prevalence of tobacco use in people suffering from psychiatric illnesses. Further research that helps to understand the possible mechanism behind this association is required. Nicotine dependence should be routinely assessed in tobacco users as it may have implications in successful quitting. Treatment approaches should be tailored in tobacco users with comorbid psychiatric disorders, as this specific population has high prevalence of tobacco use and higher nicotine dependence.
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